Option Care Health Inc. (OPCH) Insider Trading

Last 12 months

Insiders bought $2.86M and sold $1.17M on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director R Carter Pate sold $971k on Feb 27, 72% of their stake, outside a plan.

Net open-market

+$1.69M

5 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

4 / 2

executives and directors

Last open-market buy

May 2026

May 7, 2026

Get an email when OPCH's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 7	Timothy P Sullivan Director	Bought	24,154	$20.69	$500k	49%	Form 4
May 4	Harry M Jansen Kraemer Jr Director	Bought	36,610	$21.41	$784k	8.9%	Form 4
May 4	Meenal Sethna Chief Financial Officer	Bought	16,225	$20.16	$327k	20%	Form 4
May 4	John Charles Rademacher Chief Executive Officer	Bought	12,500	$21.18	$265k	1.8%	Form 4
Feb 27	R Carter Pate Director	SoldNo plan	30,287	$32.05	$971k	72%	Form 4
Feb 27	Michael Bavaro Chief Human Resources Officer	SoldNo plan	6,000	$33.00	$198k	15%	Form 4
Nov 3, 2025	Harry M Jansen Kraemer Jr Director	Bought	38,000	$25.98	$987k	10%	Form 4
Sep 9, 2025	Norman L. Wright Director	Bought	3,411	$29.31	$100k	28%	Form 4
Aug 21, 2025	Timothy P Sullivan Director	Bought	20,000	$27.51	$550k	68%	Form 4
Aug 21, 2025	David W Golding Director	Bought	1,000	$27.63	$28k	0.9%	Form 4
Aug 20, 2025	R Carter Pate Director	Bought	750	$27.19	$20k	1.8%	Form 4
Aug 20, 2025	Harry M Jansen Kraemer Jr Director	Bought	36,000	$27.15	$977k	11%	Form 4
Feb 28, 2025	Michael Bavaro Chief Human Resources Officer	SoldNo plan	30,996	$33.26	$1.03M	41%	Form 4
Nov 8, 2024	Harry M Jansen Kraemer Jr Director	Bought	43,000	$22.54	$969k	15%	Form 4

May 7
Timothy P Sullivan
Director · bought 24,154 at $20.69
$500k
49% of stake
May 4
Harry M Jansen Kraemer Jr
Director · bought 36,610 at $21.41
$784k
8.9% of stake
May 4
Meenal Sethna
Chief Financial Officer · bought 16,225 at $20.16
$327k
20% of stake
May 4
John Charles Rademacher
Chief Executive Officer · bought 12,500 at $21.18
$265k
1.8% of stake
Feb 27No plan
R Carter Pate
Director · sold 30,287 at $32.05
$971k
72% of stake
Feb 27No plan
Michael Bavaro
Chief Human Resources Officer · sold 6,000 at $33.00
$198k
15% of stake
Nov 3, 2025
Harry M Jansen Kraemer Jr
Director · bought 38,000 at $25.98
$987k
10% of stake
Sep 9, 2025
Norman L. Wright
Director · bought 3,411 at $29.31
$100k
28% of stake
Aug 21, 2025
Timothy P Sullivan
Director · bought 20,000 at $27.51
$550k
68% of stake
Aug 21, 2025
David W Golding
Director · bought 1,000 at $27.63
$28k
0.9% of stake
Aug 20, 2025
R Carter Pate
Director · bought 750 at $27.19
$20k
1.8% of stake
Aug 20, 2025
Harry M Jansen Kraemer Jr
Director · bought 36,000 at $27.15
$977k
11% of stake
Feb 28, 2025No plan
Michael Bavaro
Chief Human Resources Officer · sold 30,996 at $33.26
$1.03M
41% of stake
Nov 8, 2024
Harry M Jansen Kraemer Jr
Director · bought 43,000 at $22.54
$969k
15% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch OPCH, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Home Health Care Services

AHCOAdaptHealth Corp.

AVAHAveanna Healthcare Holdings Inc.

CHEChemed Corporation

ADUSAddus HomeCare Corporation

EHABEnhabit, Inc.

BTSGBrightSpring Health Services, Inc.

PACSPacs Group Inc.

SEMSelect Medical Holdings Corp.

Spot a number that looks wrong? Check it in OPCH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing OPCH

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.